Marta Rybczynski

Conference Coverage

HRQOL With Nivolumab Plus Chemo vs Chemo Alone Among Patients With Gastrointestinal Cancers

10/04/2021

Compared with chemotherapy alone, nivolumab added to chemotherapy maintained health-related quality of life with a decreased risk of symptom deterioration in patients with previously untreated advanced or metastatic gastric...

Compared with chemotherapy...

10/04/2021

Journal of Clinical Pathways

News

Real-World Effectiveness of Immunotherapy Among Patients With Pre-treated, Advanced NSCLC

04/05/2022

Marta Rybczynski ;

Study findings shed light on survival outcomes among vulnerable groups of pre-treated patients with advanced NSCLC receiving immunotherapy, who are often excluded from real-world clinical trials.

Study findings shed light on...

04/05/2022

Journal of Clinical Pathways

News

Anlotinib Safe, Effective as Third- or Later-line Treatment for Refractory SCLC

12/03/2021

Marta Rybczynski ;

Results from a real-world study show anlotinib is beneficial for patients with refractory SCLC as third- or further-line treatment with manageable adverse effects.

Results from a real-world study...

12/03/2021

Journal of Clinical Pathways

Conference Coverage

Assessing the Impact of COVID-19 on Prescribing Patterns in Multiple Myeloma

09/30/2022

Marta Rybczynski ;

While the total number of new therapy starts in multiple myeloma (MM) decreased during COVID-19, the rate of new starts for both intravenous and oral therapies in MM significantly increased, according to study findings presented at the 2022...

While the total number of new...

09/30/2022

Journal of Clinical Pathways

News

Cost-Effectiveness of Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for Ovarian Cancer Prevention

02/24/2022

Marta Rybczynski ;

Opportunistic salpingectomy at the time of elective cholecystectomy may be a cost-effective strategy to prevent ovarian cancer among average risk women.

Opportunistic salpingectomy at...

02/24/2022

Journal of Clinical Pathways

Conference Coverage

Trends in Total and Out-of-Pocket Cost Among Privately Insured Patients With Cancer

10/04/2021

Marta Rybczynski ;

The rise in cancer treatment costs in combination with the increase of cost-sharing have financially burdened privately insured, nonelderly patients with cancer.

The rise in cancer treatment...

10/04/2021

Journal of Clinical Pathways

News

Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among US Patients With Early-Stage NSCLC

04/05/2022

Marta Rybczynski ;

Among participants in a screening protocol for adjuvant clinical trials for resected early-stage NSCLC, only about half underwent adequate lymph node dissection and received adjuvant chemotherapy, despite guideline indications.

Among participants in a...

04/05/2022

Journal of Clinical Pathways

News

Ibrutinib Safe, Effective for the Treatment of Relapsed/Refractory CLL

12/07/2021

Marta Rybczynski ;

Findings from a real-world study suggest that using single-agent ibrutinib for relapsed/refractory CLL is safe and effective in routine clinical practice.

Findings from a real-world study...

12/07/2021

Journal of Clinical Pathways

Conference Coverage

Testing Hospital-Based Financial Toxicity Interventions at Memorial Sloan Kettering Cancer Center

10/01/2022

Marta Rybczynski ;

At least a quarter of patients at Memorial Sloan Kettering Cancer Center suffer with financial difficulties related to cancer treatment, suggesting a need for systems-based interventions to proactively assess financial toxicity risk and refer...

At least a quarter of patients...

10/01/2022

Journal of Clinical Pathways

News

Disease Progression After Olaparib Maintenance Prognosticates Poor Response to Subsequent Platinum-Based Chemotherapy in Ovarian Cancer

03/01/2022

Marta Rybczynski ;

Patients with platinum-sensitive, recurrent ovarian cancer whose disease progressed following olaparib maintenance experienced poor response to subsequent platinum-based chemotherapy, according to a recent study.

Patients with...

03/01/2022

Journal of Clinical Pathways